U-Shaped Link for BMI at DX With Mortality in DM2

U-Shaped Link for BMI at Diagnosis With Mortality in Type 2 Diabetes | insureintell.com.

CONCLUSIONS Patients categorized as normal weight or obese with T2DM within a year of diagnosis of T2DM exhibit variably higher mortality outcomes compared with the overweight group, confirming a U-shaped association of BMI with mortality. Whether weight-loss interventions reduce mortality in all T2DM patients requires study.

via The Association Between BMI Measured Within a Year After Diagnosis of Type 2 Diabetes and Mortality.

HT – Hank George

Simple Sit Test Predicts Long Life

This study evaluated the association between the ability to sit and rise from the floor with and without support and all-cause mortality in adults age 51 to 80.

There was a significant association between the use of more support to sit and rise from the floor and increasing all-cause mortality.

via Simple Sit Test Predicts Long Life.

Our profession typically uses chair-to-stand testing as part of a senior supplement.  Should we be considering the use of the sit-rise test instead?

jennovafoodblog's avatarjennovafoodblog

And I’m done exams, wohoo!! No more classes until January 7th :D! I really want to focus on my blog this Christmas break; I’ve got a few topics in mind before I start researching the suggested topics from some of you guys. If any of you have any requests, feel free to ask and I’ll make a list and eventually get to it :).

My roommate and I had our Christmas party last night, couldn’t have asked for a better group of people who came; it was a really nice reward after all of our exams :). After spending most of the day climbing (obviously), we came home and decorated the house with Christmas lights, homemade snowflakes and a cardboard Christmas tree I taped to the wall :P. I definitely feel the holiday spirit now, ready to get onto some vegan holiday creations!

Here’s a picture taken of me in…

View original post 702 more words

FDA Warns Chantix May Up Heart Risk

A meta-analysis ordered by the agency and conducted by drugmaker Pfizer found a higher occurrence of major adverse cardiovascular events — including death, MI, and stroke — with the drug than with placebo.

The FDA noted, however, that such events were uncommon in both groups, and the increased risk wasn’t statistically significant.

via Chantix May Up Heart Risk, FDA Warns.

Quitting smoking is good.  Maybe quitting smoking without a pharmaceutical assist is better.  Additional link to the FDA release follows.

Safety Alerts for Human Medical Products > Chantix (Varenicline): Safety Communication – Updated Safety Review On The Risk of Cardiovascular Adverse Events.